SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001694665-23-000146
Filing Date
2023-08-14
Accepted
2023-08-14 08:14:10
Documents
77
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q evlo-20230630.htm   iXBRL 10-Q 1334021
2 EX-31.1 exhibit311ceo302certificat.htm EX-31.1 13484
3 EX-31.2 exhibit312cfo302certificat.htm EX-31.2 13509
4 EX-32.1 exhibit321ceo906certificat.htm EX-32.1 8095
5 EX-32.2 exhibit322cfo906certificat.htm EX-32.2 7453
11 evlo-20230630_g1.jpg GRAPHIC 7885
  Complete submission text file 0001694665-23-000146.txt   6033678

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT evlo-20230630.xsd EX-101.SCH 44075
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT evlo-20230630_cal.xml EX-101.CAL 53777
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT evlo-20230630_def.xml EX-101.DEF 205082
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT evlo-20230630_lab.xml EX-101.LAB 587422
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT evlo-20230630_pre.xml EX-101.PRE 380148
71 EXTRACTED XBRL INSTANCE DOCUMENT evlo-20230630_htm.xml XML 602632
Mailing Address 620 MEMORIAL DRIVE SUITE 500 CAMBRIDGE MA 02139
Business Address 620 MEMORIAL DRIVE SUITE 500 CAMBRIDGE MA 02139 617-577-0300
Evelo Biosciences, Inc. (Filer) CIK: 0001694665 (see all company filings)

IRS No.: 465594527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38473 | Film No.: 231166457
SIC: 2834 Pharmaceutical Preparations